First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
2018 · Journal of Translational Medicine · 528 citations
https://doi.org/10.1186/s12967-018-1507-6
K
Keyoumars Ashkan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
405
Papers
12.3K
Citations
51
h-index
181
i10-index
Keyoumars Ashkan is an academic researcher from King's College - North Carolina. The author has contributed to research in topics: Neurological disorders and treatments & Parkinson's Disease Mechanisms and Treatments & Glioma Diagnosis and Treatment. The author has an h-index of 51, co-authored 345 publications.
Papers by this author
worksFunctional reorganization in obstructive sleep apnoea and insomnia: A systematic review of the resting-state fMRI
2017 · Neuroscience & Biobehavioral Reviews · 167 citations
https://doi.org/10.1016/j.neubiorev.2017.03.013
Mast cells in meningiomas and brain inflammation
2015 · Journal of Neuroinflammation · 90 citations
https://doi.org/10.1186/s12974-015-0388-3
Human subthalamic nucleus–medial frontal cortex theta phase coherence is involved in conflict and error related cortical monitoring
2016 · NeuroImage · 84 citations
https://doi.org/10.1016/j.neuroimage.2016.05.031
The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson’s disease
2013 · Journal of Neurology · 80 citations
https://doi.org/10.1007/s00415-013-7148-z
Tremor Reduction by Deep Brain Stimulation Is Associated With Gamma Power Suppression in Parkinson’s Disease
2015 · Neuromodulation Technology at the Neural Interface · 70 citations
https://doi.org/10.1111/ner.12297
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat